A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. (2021)

First Author: ACTIV-3/TICO LY-CoV555 Study Group
Attributed to:  Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2033130

PubMed Identifier: 33356051

Publication URI: http://europepmc.org/abstract/MED/33356051

Type: Journal Article/Review

Volume: 384

Parent Publication: The New England journal of medicine

Issue: 10

ISSN: 0028-4793